{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:00:19Z","timestamp":1760122819423,"version":"3.37.3"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Jagiellonian University Medical College","doi-asserted-by":"publisher","award":["K\/ZDS\/007717"],"award-info":[{"award-number":["K\/ZDS\/007717"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinecjc.ca","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.cjca.2019.01.014","type":"journal-article","created":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T03:53:38Z","timestamp":1548820418000},"page":"634-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)"],"prefix":"10.1016","volume":"35","author":[{"given":"B\u0142a\u017cej","family":"G\u0142owicki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5788-575X","authenticated-orcid":false,"given":"Pawe\u0142 T.","family":"Matusik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Plens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.01.014_bib1","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/eurheartj\/ehn599","article-title":"Stroke in paroxysmal atrial fibrillation: report from the Stockholm Cohort of Atrial Fibrillation","volume":"31","author":"Friberg","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.01.014_bib2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on Atrial Fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cjca.2019.01.014_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","article-title":"Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score","volume":"65","author":"Lip","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","article-title":"Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?","volume":"65","author":"Chao","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib5","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.01.014_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2014.03.022","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society","volume":"64","author":"January","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib7","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","article-title":"2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1159\/000083815","article-title":"Atrial fibrillation and the hypercoagulable state: from basic science to clinical practice","volume":"33","author":"Choudhury","year":"2003","journal-title":"Pathophysiol Haemost Thromb"},{"key":"10.1016\/j.cjca.2019.01.014_bib9","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1016\/j.jacc.2012.04.063","article-title":"Inflammation in atrial fibrillation","volume":"60","author":"Guo","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib10","doi-asserted-by":"crossref","first-page":"758","DOI":"10.5603\/KP.a2017.0077","article-title":"AssesSment of the left atrial appendage morphoLogy in patients aAfter ischaeMic Stroke\u2014the ASSAM study protocol","volume":"75","author":"Baran","year":"2017","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.01.014_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/0002-8703(93)90022-2","article-title":"Hemodynamic and hemorheologic determinants of left atrial spontaneous echo contrast and thrombus formation in patients with idiopathic dilated cardiomyopathy","volume":"125","author":"Siostrzonek","year":"1993","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2019.01.014_bib12","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2017.01.057","article-title":"Prethrombotic state in young very low-risk patients with atrial fibrillation","volume":"69","author":"Hobbelt","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1023\/B:THRO.0000024053.45693.fc","article-title":"Atrial fibrillation and hypercoagulability: dependent on clinical factors or\/and on genetic alterations?","volume":"16","author":"Hatzinikolaou-Kotsakou","year":"2003","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.cjca.2019.01.014_bib14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.amjcard.2004.02.032","article-title":"Relation of interleukin-6, C-reactive protein, and the prothrombotic state to transesophageal echocardiographic findings in atrial fibrillation","volume":"93","author":"Conway","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib15","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"Drabik","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.01.014_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1160\/TH14-01-0032","article-title":"Fibrin clot properties and their modulation in thrombotic disorders","volume":"112","author":"Undas","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.01.014_bib17","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/ATVBAHA.117.308564","article-title":"Fibrinogen and fibrin in hemostasis and thrombosis","volume":"37","author":"Kattula","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cjca.2019.01.014_bib18","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/STROKEAHA.117.018143","article-title":"Fibrin clot permeability as a predictor of stroke and bleeding in anticoagulated patients with atrial fibrillation","volume":"48","author":"Drabik","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2019.01.014_bib19","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2 diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.cjca.2019.01.014_bib20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/hrt.2010.192740","article-title":"Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism","volume":"96","author":"Palka","year":"2010","journal-title":"Heart"},{"key":"10.1016\/j.cjca.2019.01.014_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.5482\/HAMO-14-09-0039","article-title":"The vulnerable blood. Coagulation and clot structure in diabetes mellitus","volume":"35","author":"Hess","year":"2015","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.cjca.2019.01.014_bib22","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2017.05.060","article-title":"Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation","volume":"243","author":"Matusik","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2019.01.014_bib23","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1160\/TH06-07-0408","article-title":"Thrombin generation, a function test of the haemostatic-thrombotic system","volume":"96","author":"Hemker","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.01.014_bib24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.thromres.2012.10.011","article-title":"Data management in thrombin generation","volume":"131","author":"Hemker","year":"2013","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.01.014_bib25","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1538-7836.2012.04883.x","article-title":"An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values","volume":"10","author":"Pieters","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.01.014_bib26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cjca.2019.01.014_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1160\/TH11-09-0662","article-title":"A\u00a0history of early stent thrombosis is associated with prolonged clot lysis time","volume":"107","author":"Pankiw-Bembenek","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.01.014_bib28","series-title":"Applied Logistic Regression","first-page":"95","author":"Hosmer","year":"2000"},{"key":"10.1016\/j.cjca.2019.01.014_bib29","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.5603\/KP.2018.0134","article-title":"Association of cardiac troponin I with prothrombotic alterations in atrial fibrillation","volume":"76","author":"Matusik","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.01.014_bib30","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1093\/eurheartj\/ehx584","article-title":"A\u00a0biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score","volume":"39","author":"Hijazi","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.01.014_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.blre.2006.11.001","article-title":"Thrombin generation and fibrin clot structure","volume":"21","author":"Wolberg","year":"2007","journal-title":"Blood Rev"},{"key":"10.1016\/j.cjca.2019.01.014_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/eurheartj\/ehw119","article-title":"Hypercoagulability causes atrial fibrosis and promotes atrial fibrillation","volume":"38","author":"Spronk","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.01.014_bib33","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.5603\/KP.a2018.0149","article-title":"Transcatheter closure of atrial septal communication: impact on P-wave dispersion, duration, and arrhythmia in mid-term follow-up","volume":"76","author":"Lelakowska","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.01.014_bib34","doi-asserted-by":"crossref","first-page":"41565","DOI":"10.1038\/srep41565","article-title":"Does von Willebrand factor improve the predictive ability of current risk stratification scores in patients with atrial fibrillation?","volume":"7","author":"Garcia-Fernandez","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cjca.2019.01.014_bib35","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1111\/j.1538-7836.2012.04853.x","article-title":"Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study","volume":"10","author":"Mikkelsen","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.01.014_bib36","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/qjmed\/hcu054","article-title":"Is female sex a risk factor for stroke and thromboembolism in patients with atrial fibrillation? A systematic review and meta-analysis","volume":"107","author":"Wagstaff","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.cjca.2019.01.014_bib37","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","article-title":"Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions","volume":"109","author":"Undas","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.cjca.2019.01.014_bib38","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/europace\/eut333","article-title":"Atrial fibrillation patients do not benefit from acetylsalicylic acid","volume":"16","author":"Sjalander","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2019.01.014_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12933-017-0515-9","article-title":"Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk","volume":"16","author":"Kearney","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.cjca.2019.01.014_bib40","doi-asserted-by":"crossref","first-page":"873","DOI":"10.20452\/pamw.4165","article-title":"Plasma fibrin clot structure and thromboembolism: clinical implications","volume":"127","author":"Zabczyk","year":"2017","journal-title":"Pol Arch Intern Med"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19300509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19300509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T12:05:09Z","timestamp":1573819509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19300509"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0828282X19300509"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.01.014","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prothrombotic State in Atrial Fibrillation Patients With One Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex)","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}